期刊文献+

氯沙坦钾联合辛伐他汀对糖尿病腹膜透析患者氧化应激的影响 被引量:8

The effects of losartan potassium and simvastatin combination therapy on oxidative stress indicators in diabetic patients on peritoneal dialysis
下载PDF
导出
摘要 目的对比观察期为12周的氯沙坦钾与辛伐他汀联合治疗对糖尿病腹膜透析患者氧化应激指标的影响。方法收集2型糖尿病合并糖尿病肾病终末期新进入持续不卧床腹膜透析(CAPD)的患者80例,随机分为2组:对照组40例腹膜透析及常规治疗;治疗组40例在对照组基础上给予氯沙坦钾50 mg,1次/d,辛伐他汀分散片20mg,每晚1次。对比2组透析前及透析12周后糖化血红蛋白(HbAlC)、胰岛素用量、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-PX)、丙二醛(MDA)、同型半胱氨酸(Hcy)等指标变化。结果 2组HbA1C治疗前后及组间差异均无统计学意义(P>0.05),2组在CAPD治疗后所用胰岛素剂量均较透析前增加,其中治疗组低于对照组(P<0.05);透析后,治疗组SOD、GSH-PX表达水平均高于治疗前和对照组,MDA和Hcy均低于治疗前和对照组(P<0.05);对照组GSH-PX水平低于透析前,MDA和Hcy则高于治疗前(P<0.05)。结论氯沙坦钾联合辛伐他汀对糖尿病腹膜透析患者氧化应激指标的改善疗效确切。 Objective To explore the effects of losartan potassium and simvastatin combination therapy on oxidative stress indicators in diabetic patients on peritoneal dialysis through 12 weeks observation. Methods Diabetic patients with end-stage nephropathy (n=80) who were treated with continuous ambulatory peritoneal dialysis were randomly divided into two groups:control group who received routine treatment (n=40), treatment group who were given losartan potassium 50 mg, once per day and simvastatin 20 mg, once every night (n=40). HbA1C, Insulin dosage, Oxidative stress indicators(SOD, GSH-PX, MDA and Hcy)were compared between two groups before and after peritoneal dialysis. Results There was no significant difference of HbA1C between the 2 groups before and after treatment(P&gt;0.05). The insulin doses increased be?fore dialysis in both groups after CAPD treatment. It is lower in the treatment group than that in the control group ( P〈0.05). The expression levels of GSH-PX and SOD in treatment group were higher while the expressions of Hcy and MDA were lower after treatment. The expressions of GSH-PX and SOD were higher while the expressions of Hcy and MDA were lower in treat?ment group than those in control group when comparing the same time point(P〈0.05). GSH-PX expression level was lower while the expressions of MDA and Hcy were higher after dialysis than those before dialysis in control group ( P〈0.05). Con?clusion Losartan potassium combined with simvastatin treatment can improve curative effect and oxidative stress indicators in diabetic patients on peritoneal dialysis.
出处 《天津医药》 CAS 2015年第12期1453-1455,共3页 Tianjin Medical Journal
关键词 腹膜透析 持续不卧床 糖尿病肾病 氧化性应激 药物疗法 联合 氯沙坦钾 辛伐他汀 peritoneal dialysis,continuous ambulatory diabetic nephropathies oxidative stress drug therapy,combina-tion Losartan potassium Simvastatin
  • 相关文献

参考文献10

二级参考文献40

  • 1李永强,马虹,董吁钢.肺炎衣原体感染增强C57BL/6J小鼠氧化应激加速动脉粥样硬化发展[J].中华心血管病杂志,2005,33(5):395-398. 被引量:2
  • 2杨前勇,邹大进.糖尿病中的氧化损伤与抗氧化研究进展[J].国际内分泌代谢杂志,2006,26(B04):8-10. 被引量:14
  • 3Tan AL,Forbes JM,Cooper ME.AGE,RAGE,and ROS in diabetic nephropathy[J].Semin Nephrol,2007,27(2):130-143. 被引量:1
  • 4Ivanov MV, Voskresenskaia ON, Zakharova NB.Indicators of endothelial dysfunction and apoptosis in chronic brain ischemia caused by arterial hypertension[J].Zh Nevrol Psikhiatr Im S S Korsakova, 2009, 109:71-72. 被引量:1
  • 5Tesauro M, Leo R, Lauro R, et al.Endothelial dysfunction and diabetes: possible role in kidney damage[J].G Ital Nefrol, 2009, 26 Suppl 46:62-70. 被引量:1
  • 6de la Sierra A, Larrousse M.Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension[J].J Hum Hypertens, 2010, 24:373-379. 被引量:1
  • 7Cozma A, Or??an O, Sampelean D, et al.Endothelial dysfunction in metabolic syndrome[J].Rom J Intern Med, 2009, 47:133-140. 被引量:1
  • 8Bernatova I, Conde MV, Kopincova J, et al.Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects[J].J Hypertens Suppl, 2009, 27:S27-S31. 被引量:1
  • 9Cybulsky MI, Gimbrone MA Jr.Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis[J].Science, 1991, 251:788-791. 被引量:1
  • 10Sun HX, Zeng DY, Li RT, et al.Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase[J].Hypertension, 2012, 60:1407-1414. 被引量:1

共引文献26

同被引文献55

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部